Last reviewed · How we verify
NCT05864807
UCon Treatment of the Symptoms of Faecal Incontinence (FI)
NA trial testing UCon in Faecal Incontinence in 30 participants. Completed in 2 February 2026.
2 February 2026
Quick facts
| Lead sponsor | InnoCon Medical |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 1 August 2023 |
| Primary completion | 2 February 2026 |
| Estimated completion | 2 February 2026 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- UCon
Conditions studied
- Faecal Incontinence — all drugs for Faecal Incontinence →
- Faecal Incontinence With Faecal Urgency — all drugs for Faecal Incontinence With Faecal Urgency →
Sponsor
InnoCon Medical
Who can join
18 and older, any sex, with Faecal Incontinence or Faecal Incontinence With Faecal Urgency. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
UCon is a medical device for treatment of the symptoms of overactive bladder and fecal incontinence (FI). It electrically stimulates the DGN through the skin to obtain modulated behaviour of the bladder/bowel musculature e.g., suppress undesired bladder/bowel activity to relieve the symptoms of the patient. This clinical investigation is designed as a single-arm, prospective, single-centre, early feasibility study.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05864807
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of UCon
Trials testing the same drug.
- NCT05368246 — Safety and Performance of UCon for the Treatment of the Symptoms of Overactive Bladder (OAB) / Bowel Dysfunction (BD) · NA · completed
Other recruiting trials for Faecal Incontinence
Currently open trials in the same condition.
- NCT07126327 — Peristeen Light Explorative Clinical Investigation · NA · recruiting
- NCT06143072 — CArE for OAsI Study: Care Pathways and Anorectal Evaluation for OASI Associated Incontinence · recruiting
- NCT06601985 — Exploring the Effect of Colonic J-pouch in Anorectal Preservation Surgery for Ultra-low Rectal Cancer. · active not recruiting
- NCT05245565 — Effects of Modified Precision Functional Sphincter-Preserving Surgery (PPS) on Ultralow Rectal Cancer · recruiting
- NCT04918329 — Functional Digestive Disorders Observatory · recruiting
Other InnoCon Medical trials
Trials by the same sponsor.
- NCT06754189 — Safety and Performance of UCon Patch Electrode · NA · recruiting
- NCT06091566 — Safety and Performance of UCon Bar Electrode for the Treatment of Overactive Bladder (OAB) and Bowel Dysfunction (BD) · NA · recruiting
- NCT05874375 — UCon Treatment of Overactive Bladder (OAB) in Males · NA · recruiting
- NCT05368246 — Safety and Performance of UCon for the Treatment of the Symptoms of Overactive Bladder (OAB) / Bowel Dysfunction (BD) · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05864807 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by InnoCon Medical
- Last refreshed: 18 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05864807.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing